Tissue engineering and microRNAs: future perspectives in regenerative medicine
Manuele Gori1, Marcella Trombetta1, Daniele Santini2
1a 1 Università Campus Bio-Medico di Roma, Tissue Engineering Lab , Rome, Italy m.gori@unicampus.it.
Expert Opinion on Biological Therapy
|July 23, 2015
Summary
MicroRNAs (miRNAs) are key regulators in tissue engineering, influencing stem cell behavior and tissue microenvironments. Manipulating miRNAs offers a promising strategy for regenerative medicine, though delivery and in vivo effects require further research.
Area of Science:
- Biomedical Research
- Regenerative Medicine
- Molecular Biology
Background:
- Tissue engineering aims to restore tissue function using strategies like biomaterials and stem cells.
- MicroRNAs (miRNAs), small noncoding RNAs, regulate gene expression and are emerging as crucial players in biological processes.
- miRNAs are recognized as novel molecular targets and therapeutics with significant potential in tissue engineering.
Purpose of the Study:
- To review recent advancements in regenerative medicine.
- To highlight the role of miRNAs in modulating gene expression, stem cell functions, and cell fate.
- To discuss miRNA's involvement in tissue microenvironment remodeling and angiogenesis.
Main Methods:
- Focus on the latest achievements in regenerative medicine.
- Analysis of miRNA functions in stem cell self-renewal, proliferation, and differentiation.
- Review of miRNA's role in tissue microenvironment and angiogenesis.
- Discussion of miRNA delivery strategies.
Main Results:
- miRNAs are key modulators of gene expression and cell fate decisions.
- miRNAs significantly influence stem cell self-renewal, proliferation, and differentiation.
- miRNAs regulate tissue microenvironment rearrangement and angiogenesis.
- Various strategies for miRNA delivery into cells and tissues have been explored.
Conclusions:
- miRNA manipulation is a viable strategy for controlling tissue engineering processes.
- Further research is needed to address challenges in miRNA delivery and in vivo application.
- miRNAs represent a promising therapeutic avenue in regenerative medicine.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
01:22MicroRNAs
24.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
01:23Tissue Renewal without Stem Cells
2.3K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
2.3K